drugset / Trial / NCT00213590

Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients

NCT00213590

Phase 3 Completed 208 enrolled University Hospital, Rouen
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to show the efficacy of reduction of cyclosporine A exposure measured by the area under the curve by Bayesian estimator on the primary prevention of degradation of the renal function in renal transplant recipients

Timeline

Start
2000-04
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide

Indications